Search - tctmd.com

Displaying 1 - 20 of 1012

Sort: Relevancy | Date

Presentation THT 2026

RV Response in Valvular Heart Disease

Presenter: Michael I. Brener

March 04, 2026

Presentation THT 2026

Ice Is Still an Option for Cold Preservation

Presenter: Michael Tong

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

The Role of the Myocardium in HFpEF

Presenter: Michael R. Zile

March 03, 2026

Presentation THT 2026

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Presenter: G. Michael Felker

March 03, 2026

Presentation THT 2026

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Presenter: Michael R. Zile

March 02, 2026

Presentation THT 2026

Framing Thoughts From the Experts

Presenter: Michael I. Brener

March 02, 2026

Presentation THT 2026

Worsening heart failure and subsequent heart failure events

Presenter: Michael Stanley Kiernan

March 02, 2026

Presentation CTO 2026

Safety and Effectiveness of Saphenous Vein Grafts for Retrograde CTO PCI

Presenter: Michaella Alexandrou

February 14, 2026

Presentation CTO 2026

Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (NASA Registry)

Presenter: Michaella Alexandrou

February 13, 2026

Presentation TCT 2025

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 28, 2025

Presentation TCT 2025

TCT 1064: Relative Contribution of High Dose Outliers to Cumulative Occupational Radiation Dose in the Catheterization Laboratory

Presenter: Michael Abiragi

October 28, 2025

Presentation TCT 2025

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Presenter: Michael Graf

October 28, 2025

Presentation TCT 2025

Surgeon's Viewpoint

Presenter: Michael J. Mack

October 28, 2025

Presentation TCT 2025

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

Presenter: Michael A. Borger

October 27, 2025

Presentation TCT 2025

TCT 916: Machine Learning to Predict Neurological Outcome after Out-of-hospital Cardiac Arrest

Presenter: Johannes Michael Altstidl

October 27, 2025

Presentation TCT 2025

What can CDT Accomplish that MT Can’t Do Faster?

Presenter: Michael Young

October 27, 2025

Advertisement

RV Response in Valvular Heart Disease

Ice Is Still an Option for Cold Preservation

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

The Role of the Myocardium in HFpEF

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Framing Thoughts From the Experts

Worsening heart failure and subsequent heart failure events

Safety and Effectiveness of Saphenous Vein Grafts for Retrograde CTO PCI

Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (NASA Registry)

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 1064: Relative Contribution of High Dose Outliers to Cumulative Occupational Radiation Dose in the Catheterization Laboratory

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Surgeon's Viewpoint

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

TCT 916: Machine Learning to Predict Neurological Outcome after Out-of-hospital Cardiac Arrest

What can CDT Accomplish that MT Can’t Do Faster?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content